Publicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (17)

2024

  1. Alpha-1 Antitrypsin Gene Variants in Patients without Severe Deficiency Diagnosed with Pulmonary Emphysema on Chest CT

    International Journal of COPD, Vol. 19, pp. 353-361

  2. Corrigendum to “Chronic respiratory diseases as a risk factor for herpes zoster infection” [Arch Bronconeumol. 2024;59(12):797–804] (Archivos de Bronconeumología (2023) 59(12) (797–804), (S0300289623002806), (10.1016/j.arbres.2023.08.010))

    Archivos de Bronconeumologia

2023

  1. Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 797-804

  2. Systemic Corticosteroids in Patients With Bronchial Asthma: A Real-Life Study

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 30-38

  3. The Clinical Profile of Patients with COPD Is Conditioned by Age

    Journal of Clinical Medicine, Vol. 12, Núm. 24

2022

  1. Real-life burden of hospitalisations due to COPD exacerbations in Spain

    ERJ Open Research, Vol. 8, Núm. 3

  2. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19

    Science Progress, Vol. 105, Núm. 1

2021

  1. Clinical Management of COPD in a Real-World Setting. A Big Data Analysis

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 94-100

  2. Tratamiento antibiótico oral de la exacerbación de la EPOC. Más allá de la COVID-19

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 429-440

2020

  1. Pneumology in the Days of COVID-19

    Archivos de Bronconeumologia

2019

  1. Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care

    Archivos de Bronconeumologia, Vol. 55, Núm. 9, pp. 478-487

2018

  1. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes

    Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567

2017

  1. The variability of respiratory symptoms and associated factors in COPD

    Respiratory Medicine, Vol. 129, pp. 165-172

2001

  1. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón)

    American Journal of Respiratory and Critical Care Medicine, Vol. 163, Núm. 7, pp. 1578-1583

1996

  1. Alteraciones respiratorias en los trastornos del movimiento

    Medicina Clinica, Vol. 107, Núm. 9, pp. 342-346

1994

  1. Airway dysfunction in patients with Parkinson's disease

    Lung, Vol. 172, Núm. 1, pp. 47-55

1992

  1. Chronic airflow limitation (first of two parts)

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 9, Núm. 3, pp. 140-148